LicianPro

PRME holders · CITADEL ADVISORS LLC 13F · PRME stock

CITADEL ADVISORS LLC Prime Medicine, Inc. Common Stock (PRME) 13F holding

CITADEL ADVISORS LLC reported 336,358 PRME shares valued at $1.2M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest PRME 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the PRME holders table.

PRME reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-31336,358$1.2MCOM
2025-12-31112,870$391.7KCOM
2025-09-30900,142$5.0MCOM
2025-06-30521,508$1.3MCOM

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.